Search Results 141-150 of 17429 for Mmol

1. Primary sclerosing cholangitis - Doctors and departments - Mayo Clinic

   Liver damage can result from this potentially serious disease in which scarring blocks the bile ducts. A liver transplant is the only known cure.

2. A Study to Evaluate the Safety and Effectiveness of BMS-986036 (pegbelfermin) in Adults with Nonalcoholic Steatophepatitis (NASH) and Compensated Liver Fibrosis - Mayo Clinic

   International normalized ratio (INR) > 1.4, unless due to therapeutic anticoagulation;; Fasting plasma glucose < 60 mg/dL (< 3.33 mmol/L) or > 350 mg/dL (> ...

3. Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis - Mayo Clinic

   Hemoglobin levels \< 8.0 g/dL (\< 5 mmol/L), or \< 7.0 g/dL (\< 4.3 mmol/L) if related to participant's SLE such as in active hemolytic anaemia * Platelet ...

4. A Study to Evaluate How Semaglutide Works Compared to Placebo in People with Type 2 Diabetes and Chronic Kidney Disease - Mayo Clinic

   HbA1c less than or equal to 10% (less than or equal to 86 mmol/mol). Renal impairment defined either by: serum creatinine-based eGFR greater than or equal ...

5. VALUE Trial - Mayo Clinic

   - Hyperkalemia (serum potassium > 5.5mmol/L) - Severe Aortic or Mitral valve stenosis or regurgitation - Epicardial CAD diagnosis - Received ...

6. Assessing the Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabetes - Mayo Clinic

   Uncontrolled hyperglycemia with a glucose level > 270 mg/dl (> 15 mmol/L) after an overnight fast or > 360 mg/dl (> 20 mmol/l) in a randomly performed ...

7. Primary sclerosing cholangitis - Doctors and departments - Mayo Clinic

   Liver damage can result from this potentially serious disease in which scarring blocks the bile ducts. A liver transplant is the only known cure.

8. A Study to Compare High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy - Mayo Clinic

   Potassium level >6.0 mmol/L. Severe acute liver failure meeting any of the following criteria: INR > 2;; AST > 500 U/L;; ALT > 500 U/L;; Bilirubin > 12 mg/dL ...

9. A Study to Evaluate the Safety and Effectiveness of CAEL-101 and Plasma Cell Dyscrasia Treatment vs. Placebo and Plasma Cell Dyscrasia Tretment to Treat Patients with Mayo Stage IIIb AL Amyloidosis

   Hypercalcemia: serum calcium \> 0.25 mmol/L (\> 1 mg/dL) higher than the ULN or \> 2.75 mmol/L (\> 11 mg/dL) OR ii. Renal insufficiency: creatinine ...

10. A Study of mRNA-3745 in Participants With Glycogen Storage Disease Type 1a (GSD1a) - Mayo Clinic

    ... millimoles/liter [mmol/L]) and symptoms of hypoglycemia in the absence of acute illness, with at least one such event in the 4 weeks before signing the ...